| Application no. and date | 19218636.9 (espacenet) (Federated) (European Patent Register), 20111103 | | Patent/reg. no. and date | DK/EP 3663399, 20211222 | | Publication date | 20200610 | | Priority no. and date | US 45629810 P, 20101103 | | EP pub. no. and date |
EP 3663399 20200610 | | Effective date | | | Applicant/owner | GC BIOPHARMA CORP., 107, Ihyeon-Ro 30Beon-Gil
Giheung-gu, Yongin-Si
16924 Gyeonggi-Do, KR | | Applicant ref. no. | 6.2112.001 | | Inventor | THANOS, Christopher, 38 Meadow Hill Drive
Tiburon, CA 94920, US,
MADISON, Edwin L, 558 48th Avenue
San Francisco, CA 94121, US,
BLOUSE, Grant Ellsworth, 1353 Bernal Avenue
Burlingame, CA 94010, US | | Representative | Holme Patent A/S, Valbygårdsvej 33, 1, 2500 Valby, DK | | Opponent | | | IPC Class | A61K 38/43 (2006.01) , C12N 15/55 (2006.01) , C12N 9/64 (2006.01) | | Title | Modificerede factor IX-polypeptider og anvendelser deraf | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
